Gastroenterology News

The FDA approved nogapendekin alfa inbakicept-pmln plus Bacillus Calmette-Guerin for the treatment of certain patients with bladder cancer, according to a press release from the manufacturer.

More than 9% of patients on glucagon-like peptide-1 receptor agonists who underwent esophagogastroduodenoscopy had retained gastric contents, although the risk for aspiration remained low, according to study results.

Vonoprazan was noninferior to high-dose IV proton pump inhibitor therapy in preventing 30-day rebleeding among patients with high-risk peptic ulcer bleeding who had achieved endoscopic hemostasis, according to data.

Whereas previous studies have shown aspirin use decreases incidence and mortality of colorectal cancer, researchers may now have insight into why this occurs, according to study results published in Cancer.

When it comes to work-life balance, providers in the past skewed more toward work than life.

Food insecurity was associated with lower odds of metabolic dysfunction-associated steatotic liver disease among patients with HIV, although the presence of diabetes increased the odds of fibrosis in this population, according to data.

The FDA has approved subcutaneous administration of Takeda Pharmaceuticals’ Entyvio for maintenance therapy in adult patients with moderate-to-severe Crohn’s disease following induction therapy via IV administration of the biologic.

In this Healio video exclusive, Jeffrey Roberts, MS, BSc, shares details about World IBS Day, April 19, which aims to raise awareness and support for patients with irritable bowel syndrome with the theme, “Light Up the Sky for IBS.”

Recipients of livers recovered by normothermic regional perfusion vs. standard super rapid recovery experienced lower rates of ischemic cholangiopathy and biliary complications, with comparable patient and graft survival, data showed.

BOSTON — “We should be embracing [AI] and trying to make this a priority to get this right, because I don’t know any alternative to get us out of this frustration right now outside of this technology,” Eric Topol, MD, said.